Published Sep 28, 2026, 5:42 PM ET · Updated 2 months ago · 2 sources
Summit Therapeutics Jumps on $2 Billion AstraZeneca Investment
bloomberg
·
Original Report
Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.